Anna Skaya is the founder of Basepaws, a pet genetics company focused on early detection, prediction, and prevention of pet diseases. In 2017, Basepaws launched its first consumer DNA test for cats, drawing parallels to the renowned 23andMe (think 23andMeow!) The company subsequently expanded its offerings to include other cat-focused health tests and recently introduced dog DNA tests. Anna prides herself on being a cat lady and has promoted feline health and products far and wide, including during her appearances on Shark Tank, where she secured an investment from Mr. Wonderful. Basepaws has since appeared on Shark Tank three separate times. In 2022, Basepaws was acquired by Zoetis (NYSE: ZTD), the largest animal health company in the world, with Anna continuing to play a pivotal role in guiding Basepaws within the larger Zoetis organization, focusing on bringing the value of genetic testing to even more pet parents. Before her journey with Basepaws, Anna co-founded the UK-based MyCityDeal, which later became a part of Groupon. She then transitioned to lead Groupon Russia, where she had full P&L responsibilities. With many years of experience in the tech and consumer pet products sectors, Anna loves to bring her entrepreneurial way of being to everything she does. Originally from Odessa, Ukraine, she now calls Miami home, where she lives with her husband, daughter, and two beloved cats. As a member of the Petco Love board, Anna's dedication to improving pet health and wellness remains at the forefront of her endeavors.